A costly therapeutic dilemma in tophaceous gout: is etanercept or rasburicase preferable?
- PMID: 15708917
- PMCID: PMC1755382
A costly therapeutic dilemma in tophaceous gout: is etanercept or rasburicase preferable?
Comment on
-
Severe gouty arthritis refractory to anti-inflammatory drugs: treatment with anti-tumour necrosis factor alpha as a new therapeutic option.Ann Rheum Dis. 2004 Oct;63(10):1351-2. doi: 10.1136/ard.2003.015743. Ann Rheum Dis. 2004. PMID: 15361402 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
